Feedback / Questions
Erbitux (cetuximab) - Eli Lilly
Braftovi (encorafenib) - Pfizer
ZEN-3694 - Zenith Capital Corp
http://clinicaltrials.gov/ct2/show/NCT06102902
Jun 20, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next